HPS Pharmacies wish to advise that Mundipharma is discontinuing the following opioid products:

  • OxyNorm® (oxycodone) capsules;
  • MS Mono® (morphine sulfate) modified-release capsules; and
  • Sevredol® (morphine sulfate) tablets

Mundipharma has provided the following estimated dates of discontinuation from the market based on current demand.

Product ARTG Estimated discontinuation date
OxyNorm® 5mg 74145 March 2025
OxyNorm® 10mg 74143 June 2024
OxyNorm® 20mg 74141 March 2025
MS Mono® 30mg 74156 September 2024
MS Mono® 60mg 74154 October 2024
MS Mono® 90mg 74152 August 2024
MS Mono® 120mg 74150 September 2024
Sevredol® 10mg 47543 July 2024
Sevredol® 20mg 214089 April 2024

These dates are estimates only and may be updated on the Medicine shortage reports database if there are any changes in demand.

Retain this notice in a prominent position, including in other related business units for at least one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact Mundipharma on 1800 188 009 or your pharmacist at HPS Pharmacies.

Download PDF

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates